Van Nuys, CA, United States of America

Stuart A Sievers

This inventor holds 17 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Chimeric Antigen Receptors. Top assignees: Kite Pharma, Inc., Adimab, LLC, University of California. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stuart A Sievers. Retrieved from https://idiyas.com/inventor/stuart-a-sievers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 94.1

 

 

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Van Nuys, CA (US) (2014 - 2023)
  • Santa Monica, CA (US) (2020 - 2023)

Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Chimeric Antigen Receptors
T Cell Receptors
Antigen Binding Molecules
Chimeric Polypeptides
Modified Receptors
Anti-CD19 scFv
Humanized Domains
Peptide Inhibitors
Methods of Use
Structure-Based Design
Fibrillation
17 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Inventor Stuart A. Sievers

Introduction

Stuart A. Sievers is a notable inventor based in Van Nuys, California. With a total of 13 patents to his name, he has made significant contributions to the field of biotechnology, particularly in developing antigen-binding molecules for therapeutic applications.

Latest Patents

Among his most recent innovations is a patent for "Antigen binding molecules specific for an anti-CD19 scFV," which provides isolated antigen-binding molecules that engage with specific sequences. Another noteworthy patent is "Antigen binding molecules and methods of use thereof," offering isolated molecules that bind to various amino acid sequences for potential clinical use. These patents showcase his commitment to advancing medical treatments through innovative approaches.

Career Highlights

Throughout his career, Stuart has worked with prominent companies such as Kite Pharma, Inc. and the University of California. His work at these institutions has allowed him to further his research and development in the field of biotechnology, making a lasting impact on scientific advancements.

Collaborations

Stuart A. Sievers has collaborated with esteemed colleagues including Jed Wiltzius and Jed J.W. Wiltzius. These professional relationships have fostered an environment of innovation and creativity, enabling groundbreaking discoveries in the realm of antigen-binding technologies.

Conclusion

Stuart A. Sievers exemplifies the spirit of innovation in biotechnology through his patents and collaborative efforts. His work holds promise for future advancements in medical therapies, underscoring the vital role of inventors in the development of new technologies that can benefit society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…